Sibyl E. Wray
Impact in
-
- Multiple Sclerosis Research Studies
-
- Neurogenesis and neuroplasticity mechanisms
Papers in
-
- Multiple Sclerosis Research Studies 59
-
- Neurogenesis and neuroplasticity mechanisms 2
- Co-authors
- Koby Mok (12 shared papers)Michael Weiss (8 shared papers)Krzysztof W. Selmaj (17 shared papers)Hans‐Peter Hartung (14 shared papers)Enrique Álvarez (11 shared papers)Paul B. Farel (4 shared papers)Matthew Gormley (3 shared papers)Amy E. Lovett‐Racke (4 shared papers)
- Journals
- Neurology (27 papers)Multiple Sclerosis Journal (5 papers)Multiple Sclerosis and Related Disorders (4 papers)Neurology and Therapy (3 papers)Expert Opinion on Drug Delivery (2 papers)
- Partner nations
- United StatesGermanyPoland
In The Last Decade
Sibyl E. Wray
59 papers receiving 1.2k citations
Sibyl E. Wray's Hit Papers
Peers
Comparison fields: 5 of 63
- Pathology and Forensic Medicine 960
- Developmental Neuroscience 25
- Family Practice 16
- Genetics 25
- Immunology 50
Countries citing papers authored by Sibyl E. Wray
This map shows the geographic impact of Sibyl E. Wray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sibyl E. Wray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sibyl E. Wray more than expected).
Fields of papers citing papers by Sibyl E. Wray
This network shows the impact of papers produced by Sibyl E. Wray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sibyl E. Wray. The network helps show where Sibyl E. Wray may publish in the future.
Co-authors
The 25 scholars most cited alongside Sibyl E. Wray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2021 | 163 |
| 2 | Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis Hit paper breakdown → | 2022 | 154 |
| 3 | 2016 | 99 | |
| 4 | 2020 | 94 | |
| 5 | 2022 | 86 | |
| 6 | 2016 | 66 | |
| 7 | 2018 | 65 | |
| 8 | 2015 | 59 | |
| 9 | 2016 | 56 | |
| 10 | 2019 | 42 | |
| 11 | 2022 | 29 | |
| 12 | 1993 | 22 | |
| 13 | 2021 | 19 | |
| 14 | 2011 | 17 | |
| 15 | 2019 | 17 | |
| 16 | 2023 | 17 | |
| 17 | 2017 | 16 | |
| 18 | 2019 | 16 | |
| 19 | 2021 | 16 | |
| 20 | 2012 | 14 |
About Sibyl E. Wray
Sibyl E. Wray is a scholar working on Pathology and Forensic Medicine, Developmental Neuroscience, Cellular and Molecular Neuroscience, Public Health, Environmental and Occupational Health and Nuclear Energy and Engineering, having authored 66 papers that have together received 1.2k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (59 papers), Pregnancy and Medication Impact (3 papers), Neurogenesis and neuroplasticity mechanisms (2 papers) and Nerve injury and regeneration (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (960 citations), Developmental Neuroscience (25 citations), Family Practice (16 citations), Genetics (25 citations) and Immunology (50 citations). Sibyl E. Wray has collaborated with scholars based in United States, Germany and Poland. Frequent co-authors include Koby Mok, Michael Weiss, Krzysztof W. Selmaj, Hans‐Peter Hartung, Enrique Álvarez, Paul B. Farel, Matthew Gormley, Amy E. Lovett‐Racke, Richard A. Shubin and Daniel R. Wynn. Their work appears in journals such as Neurology, Multiple Sclerosis Journal, Multiple Sclerosis and Related Disorders, Neurology and Therapy and Expert Opinion on Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.